Gilead Tenofovir Cases

Summary

The California Supreme Court held that a drug manufacturer does not owe a duty of reasonable care to develop and commercialize a safer alternative drug when the existing drug is nondefective, and therefore reversed the Court of Appeal, remanding with instructions to grant summary judgment for Gilead on all causes of action.